Search results for Akre Capital Management

Akre Focus ETF Q1 2026 Commentary

Reverence Capital Partners Closes $2B Osaic Recapitalization

Bain Capital will join as a new investor in the recapitalization, with some of the capital supporting Osaic’s organic growth, acquisitions and “other strategic initiatives.”

Mount Logan Capital: A Messy Alt-Manager With An Insurance Kicker

Arax Lures $1.5B Upstate NY Firm from Wells Fargo

The Poughkeepsie, N.Y.-based practice marks Arax's second acquisition in the Hudson Valley region this year. CEO Haig Ariyan previously said the firm was looking to entice W-2 empl...

Lido Advisors Acquires $1B Jackson Hole Capital

The Los Angeles wealth advisory firm has added Jackson Hole Capital Partners, which brings a team of six partners focused on alternatives.

Alger Capital Appreciation Fund Q1 2026 Commentary

WealthStack Roundup: Bill Crager's iAlta Acquires Precept

The private markets startup makes another acquisition, with more news from OneVest, Jump, DeepVest and Advisor CRM.

Wealth Management Invest: Private Credit, Liquidity Pressures and Market Signals with Chris Acito

Gapstow Capital Partners’ Chris Acito explains how the expansion of retail investor access has changed the structure of the market, and why recent redemption activity is bringing r...

AlphaCore Puts Alternatives at the Heart of its Strategy

The La Jolla, Calif. RIA allocates 20% to 25% of client portfolios to private markets, far exceeding industry norms, while maintaining international exposure across asset classes.

Ardian Announces Sale of Acousti Engineering

Ardian, a global private investment firm, announced it has signed a definitive agreement to sell its majority stake in Acousti Engineering (“Acousti” or the “Company”), a leading s...

Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy

This San Diego biotech develops targeted therapies for RAS/MAPK-driven cancers, advancing several clinical candidates in oncology.

Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy

This San Diego biotech develops targeted therapies for RAS/MAPK-driven cancers, advancing several clinical candidates in oncology.

FBDC: Actively Managed BDC Exposure

Green Arrow Capital completes acquisition of DeA Capital

The transaction creates Italy’s largest alternative investment manager by size, with €8 billion in assets under management. The post Green Arrow Capital completes acquisition of De...

AllianceBernstein, Brookfield, Carlyle Team Up on Private Markets Push for DC Plans

The three firms are collaborating on ABC [ONE], a portfolio which dynamically adjusts allocations to private credit, real estate and equity based on a participant's retirement stag...

Eagle Point Credit: Insiders Are Purchasing While NAV Is In Free Fall

Form 13F Paragon Capital Management Ltd For: 15 April

Blue Owl grows AUM and earnings despite wealth jitters

Blue Owl Capital’s assets under management (AUM) rose to $314.9bn (£231.7bn) in the first quarter of 2026, as earnings also grew despite investor jitters in its wealth channels ear...

Bill Crager to Lead New Company, Field

Combining two recent acquisitions of iAltA, the new firm will build the wealth intelligence and data layer needed by RIAs.

AB, Brookfield and Carlyle launch private markets solution for US DC plans

AllianceBernstein (AB), Brookfield Asset Management and Carlyle have unveiled a turnkey private markets solution for defined contribution (DC) plans, to give retirement savers an a...

LibreMax launches $285m ABF interval fund

LibreMax Capital has launched a private asset-backed finance (ABF) and traded structured credit interval fund, anchored by $285m (£210m) of commitments. The LibreMax Asset-Backed I...

TransUnion (TRU): Billionaire Tom Steyer Trims Position

Two Of The Best Buys I Have Seen In Years

Ares Plans a Smaller Private Credit Fund With Less Leverage

A smaller target size means a faster timeline for funds like Ares to raise and deploy capital.